Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial Article Swipe
Sun Young Rha
,
Yanqiao Zhang
,
Anneli Elme
,
Roberto Pazo-Cid
,
Ahmet Alacacıoğlu
,
Dimitrios C. Ziogas
,
Kohei Shitara
,
Anastasija Ranceva
,
Radim Němeček
,
Armando Santoro
,
Carlos Calderón
,
Krittiya Korphaisarn
,
Thomas R. A. Davis
,
Anita Zahlten-Kuemeli
,
Christopher Conn
,
Mengyao Tan
,
Hayden Honeycutt
,
Zev A. Wainberg
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1200/po-24-00710
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1200/po-24-00710
PURPOSE Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein overexpression is an emerging biomarker in gastric cancer and gastroesophageal junction cancer (GC). We assessed FGFR2b protein overexpression prevalence in nearly 3,800 tumor samples as part of the prescreening process for a global phase III study in patients with newly diagnosed advanced or metastatic GC. METHODS As of June 28, 2024, 3,782 tumor samples from prescreened patients from 37 countries for the phase III FORTITUDE-101 trial (ClinicalTrials.gov identifier: NCT05052801) were centrally tested for FGFR2b protein overexpression by immunohistochemistry (IHC) and had evaluable results. FGFR2b positivity was defined as both any % tumor cells (TC) and ≥10% TC exhibiting moderate-to-strong (2+/3+) membranous FGFR2b staining. Prevalence was analyzed across patient and sample characteristics. RESULTS FGFR2b protein overexpression at any % and ≥10%, 2+/3+ TC positivity was 37.8% (1,428/3,782 [95% CI, 36.2 to 39.3]) and 16.2% (612/3,782 [95% CI, 15 to 17.4]), respectively. Of any %, 2+/3+ TC–positive tumors, 42.9% (612/1,428 [95% CI, 40.3 to 45.4]) were FGFR2b ≥10%, 2+/3+ TC positive. FGFR2b prevalence was not notably different within multiple patient and sample characteristics examined (age, sex, collection method [biopsy v resection], collection site, location of primary tumor, and geographic region). CONCLUSION As of the data cutoff date, we report the largest prevalence assessment of FGFR2b protein overexpression in GC with more than one third (37.8%) of patients with GC exhibiting FGFR2b protein overexpression (any % TC, 2+/3+) by a validated IHC assay. Approximately 16% of patients had FGFR2b protein overexpression in ≥10% of TC. FGFR2b prevalence was similar across geographic regions and within defined patient and sample variables regardless of the level of expression.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1200/po-24-00710
- OA Status
- green
- Cited By
- 12
- References
- 28
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4406792151
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4406792151Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1200/po-24-00710Digital Object Identifier
- Title
-
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 TrialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-01-24Full publication date if available
- Authors
-
Sun Young Rha, Yanqiao Zhang, Anneli Elme, Roberto Pazo-Cid, Ahmet Alacacıoğlu, Dimitrios C. Ziogas, Kohei Shitara, Anastasija Ranceva, Radim Němeček, Armando Santoro, Carlos Calderón, Krittiya Korphaisarn, Thomas R. A. Davis, Anita Zahlten-Kuemeli, Christopher Conn, Mengyao Tan, Hayden Honeycutt, Zev A. WainbergList of authors in order
- Landing page
-
https://doi.org/10.1200/po-24-00710Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11781561Direct OA link when available
- Concepts
-
Immunohistochemistry, Biopsy, Internal medicine, Cancer, Cohort, Biomarker, Gastroenterology, Biology, Medicine, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
12Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 12Per-year citation counts (last 5 years)
- References (count)
-
28Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4406792151 |
|---|---|
| doi | https://doi.org/10.1200/po-24-00710 |
| ids.doi | https://doi.org/10.1200/po-24-00710 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39854659 |
| ids.openalex | https://openalex.org/W4406792151 |
| fwci | 32.19533554 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000378 |
| mesh[1].descriptor_ui | D051497 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | metabolism |
| mesh[1].descriptor_name | Receptor, Fibroblast Growth Factor, Type 2 |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D013274 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Stomach Neoplasms |
| mesh[3].qualifier_ui | Q000378 |
| mesh[3].descriptor_ui | D013274 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | metabolism |
| mesh[3].descriptor_name | Stomach Neoplasms |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008297 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Male |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008875 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Middle Aged |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000368 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Aged |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000328 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Adult |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D015995 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Prevalence |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D014408 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Biomarkers, Tumor |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000378 |
| mesh[12].descriptor_ui | D051497 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | metabolism |
| mesh[12].descriptor_name | Receptor, Fibroblast Growth Factor, Type 2 |
| mesh[13].qualifier_ui | Q000473 |
| mesh[13].descriptor_ui | D013274 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | pathology |
| mesh[13].descriptor_name | Stomach Neoplasms |
| mesh[14].qualifier_ui | Q000378 |
| mesh[14].descriptor_ui | D013274 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | metabolism |
| mesh[14].descriptor_name | Stomach Neoplasms |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D005260 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Female |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008297 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Male |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D008875 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Middle Aged |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000368 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Aged |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000328 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Adult |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D015995 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Prevalence |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D014408 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Biomarkers, Tumor |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000328 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Adult |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000368 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Aged |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D005260 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Female |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D006801 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Humans |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008297 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Male |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008875 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Middle Aged |
| mesh[28].qualifier_ui | Q000378 |
| mesh[28].descriptor_ui | D014408 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | metabolism |
| mesh[28].descriptor_name | Biomarkers, Tumor |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D007150 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Immunohistochemistry |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D015995 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Prevalence |
| mesh[31].qualifier_ui | Q000378 |
| mesh[31].descriptor_ui | D051497 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | metabolism |
| mesh[31].descriptor_name | Receptor, Fibroblast Growth Factor, Type 2 |
| mesh[32].qualifier_ui | Q000378 |
| mesh[32].descriptor_ui | D013274 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | metabolism |
| mesh[32].descriptor_name | Stomach Neoplasms |
| mesh[33].qualifier_ui | Q000473 |
| mesh[33].descriptor_ui | D013274 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | pathology |
| mesh[33].descriptor_name | Stomach Neoplasms |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | Q000378 |
| mesh[35].descriptor_ui | D013274 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | metabolism |
| mesh[35].descriptor_name | Stomach Neoplasms |
| mesh[36].qualifier_ui | Q000473 |
| mesh[36].descriptor_ui | D013274 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | pathology |
| mesh[36].descriptor_name | Stomach Neoplasms |
| mesh[37].qualifier_ui | Q000378 |
| mesh[37].descriptor_ui | D051497 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | metabolism |
| mesh[37].descriptor_name | Receptor, Fibroblast Growth Factor, Type 2 |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D008297 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Male |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D005260 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Female |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D008875 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Middle Aged |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D000368 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Aged |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D015995 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Prevalence |
| mesh[43].qualifier_ui | Q000378 |
| mesh[43].descriptor_ui | D014408 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | metabolism |
| mesh[43].descriptor_name | Biomarkers, Tumor |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D000328 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Adult |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D007150 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Immunohistochemistry |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006801 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Humans |
| mesh[47].qualifier_ui | Q000378 |
| mesh[47].descriptor_ui | D051497 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | metabolism |
| mesh[47].descriptor_name | Receptor, Fibroblast Growth Factor, Type 2 |
| mesh[48].qualifier_ui | Q000473 |
| mesh[48].descriptor_ui | D013274 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | pathology |
| mesh[48].descriptor_name | Stomach Neoplasms |
| mesh[49].qualifier_ui | Q000378 |
| mesh[49].descriptor_ui | D013274 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | metabolism |
| mesh[49].descriptor_name | Stomach Neoplasms |
| type | article |
| title | Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial |
| biblio.issue | 9 |
| biblio.volume | 9 |
| biblio.last_page | e2400710 |
| biblio.first_page | e2400710 |
| topics[0].id | https://openalex.org/T12287 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Fibroblast Growth Factor Research |
| topics[1].id | https://openalex.org/T11485 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9937000274658203 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2715 |
| topics[1].subfield.display_name | Gastroenterology |
| topics[1].display_name | Gastrointestinal Tumor Research and Treatment |
| topics[2].id | https://openalex.org/T10231 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9865999817848206 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Pancreatic and Hepatic Oncology Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C204232928 |
| concepts[0].level | 2 |
| concepts[0].score | 0.5655562877655029 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q899285 |
| concepts[0].display_name | Immunohistochemistry |
| concepts[1].id | https://openalex.org/C2775934546 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5321012735366821 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q179991 |
| concepts[1].display_name | Biopsy |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5309673547744751 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C121608353 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4491656422615051 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[3].display_name | Cancer |
| concepts[4].id | https://openalex.org/C72563966 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4299629330635071 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[4].display_name | Cohort |
| concepts[5].id | https://openalex.org/C2781197716 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4123797118663788 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q864574 |
| concepts[5].display_name | Biomarker |
| concepts[6].id | https://openalex.org/C90924648 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3856751620769501 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[6].display_name | Gastroenterology |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.38413551449775696 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.2784765362739563 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C55493867 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[9].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/immunohistochemistry |
| keywords[0].score | 0.5655562877655029 |
| keywords[0].display_name | Immunohistochemistry |
| keywords[1].id | https://openalex.org/keywords/biopsy |
| keywords[1].score | 0.5321012735366821 |
| keywords[1].display_name | Biopsy |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.5309673547744751 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/cancer |
| keywords[3].score | 0.4491656422615051 |
| keywords[3].display_name | Cancer |
| keywords[4].id | https://openalex.org/keywords/cohort |
| keywords[4].score | 0.4299629330635071 |
| keywords[4].display_name | Cohort |
| keywords[5].id | https://openalex.org/keywords/biomarker |
| keywords[5].score | 0.4123797118663788 |
| keywords[5].display_name | Biomarker |
| keywords[6].id | https://openalex.org/keywords/gastroenterology |
| keywords[6].score | 0.3856751620769501 |
| keywords[6].display_name | Gastroenterology |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.38413551449775696 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.2784765362739563 |
| keywords[8].display_name | Medicine |
| language | en |
| locations[0].id | doi:10.1200/po-24-00710 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4210227748 |
| locations[0].source.issn | 2473-4284 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2473-4284 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | JCO Precision Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JCO Precision Oncology |
| locations[0].landing_page_url | https://doi.org/10.1200/po-24-00710 |
| locations[1].id | pmid:39854659 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | JCO precision oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39854659 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11781561 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | JCO Precis Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11781561 |
| locations[3].id | pmh:oai:escholarship.org:ark:/13030/qt56p6n6pj |
| locations[3].is_oa | True |
| locations[3].source | |
| locations[3].license | cc-by-nc-nd |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://escholarship.org/uc/item/56p6n6pj |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5024676627 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2512-4531 |
| authorships[0].author.display_name | Sun Young Rha |
| authorships[0].countries | KR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I193775966 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea |
| authorships[0].institutions[0].id | https://openalex.org/I193775966 |
| authorships[0].institutions[0].ror | https://ror.org/01wjejq96 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I193775966 |
| authorships[0].institutions[0].country_code | KR |
| authorships[0].institutions[0].display_name | Yonsei University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sun Young Rha |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea |
| authorships[1].author.id | https://openalex.org/A5075350471 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6206-8364 |
| authorships[1].author.display_name | Yanqiao Zhang |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I156144747, https://openalex.org/I4210103956 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China |
| authorships[1].institutions[0].id | https://openalex.org/I156144747 |
| authorships[1].institutions[0].ror | https://ror.org/05jscf583 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I156144747 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Harbin Medical University |
| authorships[1].institutions[1].id | https://openalex.org/I4210103956 |
| authorships[1].institutions[1].ror | https://ror.org/01f77gp95 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210103956 |
| authorships[1].institutions[1].country_code | CN |
| authorships[1].institutions[1].display_name | Third Affiliated Hospital of Harbin Medical University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yanqiao Zhang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China |
| authorships[2].author.id | https://openalex.org/A5000732206 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0432-2261 |
| authorships[2].author.display_name | Anneli Elme |
| authorships[2].countries | EE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210093692 |
| authorships[2].affiliations[0].raw_affiliation_string | North Estonia Medical Centre Foundation, Tallinn, Estonia |
| authorships[2].institutions[0].id | https://openalex.org/I4210093692 |
| authorships[2].institutions[0].ror | https://ror.org/00kfp3012 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210093692 |
| authorships[2].institutions[0].country_code | EE |
| authorships[2].institutions[0].display_name | North Estonia Medical Centre |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anneli Elme |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | North Estonia Medical Centre Foundation, Tallinn, Estonia |
| authorships[3].author.id | https://openalex.org/A5012440329 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8026-7391 |
| authorships[3].author.display_name | Roberto Pazo-Cid |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210114530 |
| authorships[3].affiliations[0].raw_affiliation_string | Hospital Universitario Miguel Servet, Zaragoza, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210114530 |
| authorships[3].institutions[0].ror | https://ror.org/01r13mt55 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210114530 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Hospital Universitario Miguel Servet |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Roberto Pazo Cid |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Hospital Universitario Miguel Servet, Zaragoza, Spain |
| authorships[4].author.id | https://openalex.org/A5052985063 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3428-5932 |
| authorships[4].author.display_name | Ahmet Alacacıoğlu |
| authorships[4].countries | TR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I250383648 |
| authorships[4].affiliations[0].raw_affiliation_string | Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma Hastanesi, Menemen, Turkey |
| authorships[4].institutions[0].id | https://openalex.org/I250383648 |
| authorships[4].institutions[0].ror | https://ror.org/024nx4843 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I250383648 |
| authorships[4].institutions[0].country_code | TR |
| authorships[4].institutions[0].display_name | Izmir Kâtip Çelebi University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ahmet Alacacioglu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma Hastanesi, Menemen, Turkey |
| authorships[5].author.id | https://openalex.org/A5058973451 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2620-4004 |
| authorships[5].author.display_name | Dimitrios C. Ziogas |
| authorships[5].countries | GR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I200777214, https://openalex.org/I4210114623 |
| authorships[5].affiliations[0].raw_affiliation_string | First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece |
| authorships[5].institutions[0].id | https://openalex.org/I4210114623 |
| authorships[5].institutions[0].ror | https://ror.org/02dvs1389 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210114623 |
| authorships[5].institutions[0].country_code | GR |
| authorships[5].institutions[0].display_name | Laiko General Hospital of Athens |
| authorships[5].institutions[1].id | https://openalex.org/I200777214 |
| authorships[5].institutions[1].ror | https://ror.org/04gnjpq42 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I200777214 |
| authorships[5].institutions[1].country_code | GR |
| authorships[5].institutions[1].display_name | National and Kapodistrian University of Athens |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Dimitrios C. Ziogas |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece |
| authorships[6].author.id | https://openalex.org/A5015799240 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5196-3630 |
| authorships[6].author.display_name | Kohei Shitara |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210145079 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa City, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I4210145079 |
| authorships[6].institutions[0].ror | https://ror.org/03rm3gk43 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210145079 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | National Cancer Center Hospital East |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kohei Shitara |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa City, Japan |
| authorships[7].author.id | https://openalex.org/A5066219755 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8320-7100 |
| authorships[7].author.display_name | Anastasija Ranceva |
| authorships[7].countries | LT |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I173212132 |
| authorships[7].affiliations[0].raw_affiliation_string | Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania |
| authorships[7].institutions[0].id | https://openalex.org/I173212132 |
| authorships[7].institutions[0].ror | https://ror.org/03nadee84 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I173212132 |
| authorships[7].institutions[0].country_code | LT |
| authorships[7].institutions[0].display_name | Vilnius University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Anastasija Ranceva |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania |
| authorships[8].author.id | https://openalex.org/A5029943774 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6825-0960 |
| authorships[8].author.display_name | Radim Němeček |
| authorships[8].countries | CZ |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I21449261, https://openalex.org/I4210115043 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Masaryk University, Faculty of Medicine, Brno, Czech Republic |
| authorships[8].institutions[0].id | https://openalex.org/I4210115043 |
| authorships[8].institutions[0].ror | https://ror.org/0270ceh40 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210115043 |
| authorships[8].institutions[0].country_code | CZ |
| authorships[8].institutions[0].display_name | Masaryk Memorial Cancer Institute |
| authorships[8].institutions[1].id | https://openalex.org/I21449261 |
| authorships[8].institutions[1].ror | https://ror.org/02j46qs45 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I21449261 |
| authorships[8].institutions[1].country_code | CZ |
| authorships[8].institutions[1].display_name | Masaryk University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Radim Nemecek |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Masaryk University, Faculty of Medicine, Brno, Czech Republic |
| authorships[9].author.id | https://openalex.org/A5100766578 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-1709-9492 |
| authorships[9].author.display_name | Armando Santoro |
| authorships[9].countries | IT |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210163047 |
| authorships[9].affiliations[0].raw_affiliation_string | Medical Oncology and Haematology Unit, IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I1339471597 |
| authorships[9].affiliations[1].raw_affiliation_string | Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy |
| authorships[9].institutions[0].id | https://openalex.org/I1339471597 |
| authorships[9].institutions[0].ror | https://ror.org/020dggs04 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I1339471597 |
| authorships[9].institutions[0].country_code | IT |
| authorships[9].institutions[0].display_name | Humanitas University |
| authorships[9].institutions[1].id | https://openalex.org/I4210163047 |
| authorships[9].institutions[1].ror | https://ror.org/05d538656 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210153126, https://openalex.org/I4210163047 |
| authorships[9].institutions[1].country_code | IT |
| authorships[9].institutions[1].display_name | IRCCS Humanitas Research Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Armando Santoro |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy, Medical Oncology and Haematology Unit, IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy |
| authorships[10].author.id | https://openalex.org/A5108062315 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-3962-4828 |
| authorships[10].author.display_name | Carlos Calderón |
| authorships[10].countries | CO |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210095963 |
| authorships[10].affiliations[0].raw_affiliation_string | Fundacion Cardiovascular de Colombia, Bucaramanga, Colombia |
| authorships[10].institutions[0].id | https://openalex.org/I4210095963 |
| authorships[10].institutions[0].ror | https://ror.org/00q67qp92 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210095963 |
| authorships[10].institutions[0].country_code | CO |
| authorships[10].institutions[0].display_name | Fundación Cardiovascular de Colombia |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Carlos Alberto Calderon |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Fundacion Cardiovascular de Colombia, Bucaramanga, Colombia |
| authorships[11].author.id | https://openalex.org/A5022986629 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5739-0175 |
| authorships[11].author.display_name | Krittiya Korphaisarn |
| authorships[11].countries | TH |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1332387789, https://openalex.org/I25399158 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand |
| authorships[11].institutions[0].id | https://openalex.org/I25399158 |
| authorships[11].institutions[0].ror | https://ror.org/01znkr924 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I25399158 |
| authorships[11].institutions[0].country_code | TH |
| authorships[11].institutions[0].display_name | Mahidol University |
| authorships[11].institutions[1].id | https://openalex.org/I1332387789 |
| authorships[11].institutions[1].ror | https://ror.org/0331zs648 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I1332387789 |
| authorships[11].institutions[1].country_code | TH |
| authorships[11].institutions[1].display_name | Siriraj Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Krittiya Korphaisarn |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand |
| authorships[12].author.id | https://openalex.org/A5110385838 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Thomas R. A. Davis |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I129302853 |
| authorships[12].affiliations[0].raw_affiliation_string | Roche Diagnostics Solutions, Tucson, AZ |
| authorships[12].institutions[0].id | https://openalex.org/I129302853 |
| authorships[12].institutions[0].ror | https://ror.org/011qkaj49 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I118019719, https://openalex.org/I129302853 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Roche (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Tracy Davis |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Roche Diagnostics Solutions, Tucson, AZ |
| authorships[13].author.id | https://openalex.org/A5047985820 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Anita Zahlten-Kuemeli |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1320553840 |
| authorships[13].affiliations[0].raw_affiliation_string | Amgen, Inc, Thousand Oaks, CA |
| authorships[13].institutions[0].id | https://openalex.org/I1320553840 |
| authorships[13].institutions[0].ror | https://ror.org/03g03ge92 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I1320553840 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Amgen (United States) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Anita Zahlten-Kuemeli |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Amgen, Inc, Thousand Oaks, CA |
| authorships[14].author.id | https://openalex.org/A5010902060 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Christopher Conn |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I1320553840 |
| authorships[14].affiliations[0].raw_affiliation_string | Amgen, Inc, Thousand Oaks, CA |
| authorships[14].institutions[0].id | https://openalex.org/I1320553840 |
| authorships[14].institutions[0].ror | https://ror.org/03g03ge92 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I1320553840 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Amgen (United States) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Christopher Conn |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Amgen, Inc, Thousand Oaks, CA |
| authorships[15].author.id | https://openalex.org/A5112905073 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Mengyao Tan |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1320553840 |
| authorships[15].affiliations[0].raw_affiliation_string | Amgen, Inc, Thousand Oaks, CA |
| authorships[15].institutions[0].id | https://openalex.org/I1320553840 |
| authorships[15].institutions[0].ror | https://ror.org/03g03ge92 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I1320553840 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Amgen (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Mengyao Tan |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Amgen, Inc, Thousand Oaks, CA |
| authorships[16].author.id | https://openalex.org/A5059255601 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Hayden Honeycutt |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1320553840 |
| authorships[16].affiliations[0].raw_affiliation_string | Amgen, Inc, Thousand Oaks, CA |
| authorships[16].institutions[0].id | https://openalex.org/I1320553840 |
| authorships[16].institutions[0].ror | https://ror.org/03g03ge92 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I1320553840 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Amgen (United States) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Hayden Honeycutt |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Amgen, Inc, Thousand Oaks, CA |
| authorships[17].author.id | https://openalex.org/A5019473289 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-7142-1246 |
| authorships[17].author.display_name | Zev A. Wainberg |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[17].affiliations[0].raw_affiliation_string | Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA |
| authorships[17].institutions[0].id | https://openalex.org/I161318765 |
| authorships[17].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | University of California, Los Angeles |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Zev A. Wainberg |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11781561 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12287 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Fibroblast Growth Factor Research |
| related_works | https://openalex.org/W2999877485, https://openalex.org/W2355920994, https://openalex.org/W2399421402, https://openalex.org/W2376996112, https://openalex.org/W2773349476, https://openalex.org/W2782824587, https://openalex.org/W2101676003, https://openalex.org/W4200568016, https://openalex.org/W2371177287, https://openalex.org/W3209826648 |
| cited_by_count | 12 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 12 |
| locations_count | 4 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11781561 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | JCO Precis Oncol |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11781561 |
| primary_location.id | doi:10.1200/po-24-00710 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4210227748 |
| primary_location.source.issn | 2473-4284 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2473-4284 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | JCO Precision Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JCO Precision Oncology |
| primary_location.landing_page_url | https://doi.org/10.1200/po-24-00710 |
| publication_date | 2025-01-24 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4393935425, https://openalex.org/W4288734447, https://openalex.org/W2626196723, https://openalex.org/W4384201492, https://openalex.org/W2100439220, https://openalex.org/W4387812259, https://openalex.org/W4391610423, https://openalex.org/W3171517418, https://openalex.org/W4220909053, https://openalex.org/W4387849849, https://openalex.org/W4304182662, https://openalex.org/W3129804534, https://openalex.org/W2270058733, https://openalex.org/W2400239962, https://openalex.org/W4401357972, https://openalex.org/W4306150184, https://openalex.org/W4391514762, https://openalex.org/W2087913420, https://openalex.org/W2044611614, https://openalex.org/W2091448280, https://openalex.org/W2071416889, https://openalex.org/W2002215779, https://openalex.org/W2044513926, https://openalex.org/W2000369564, https://openalex.org/W2135990563, https://openalex.org/W3158415488, https://openalex.org/W3145734939, https://openalex.org/W4400239643 |
| referenced_works_count | 28 |
| abstract_inverted_index.% | 100, 127, 232 |
| abstract_inverted_index.2 | 5 |
| abstract_inverted_index.a | 41, 236 |
| abstract_inverted_index.v | 187 |
| abstract_inverted_index.%, | 152 |
| abstract_inverted_index.15 | 146 |
| abstract_inverted_index.37 | 68 |
| abstract_inverted_index.As | 56, 199 |
| abstract_inverted_index.GC | 216, 226 |
| abstract_inverted_index.Of | 150 |
| abstract_inverted_index.TC | 106, 131, 167 |
| abstract_inverted_index.We | 23 |
| abstract_inverted_index.an | 12 |
| abstract_inverted_index.as | 34, 97 |
| abstract_inverted_index.at | 125 |
| abstract_inverted_index.by | 86, 235 |
| abstract_inverted_index.in | 15, 29, 46, 215, 248 |
| abstract_inverted_index.is | 11 |
| abstract_inverted_index.of | 36, 57, 192, 200, 211, 223, 242, 250, 267, 270 |
| abstract_inverted_index.or | 52 |
| abstract_inverted_index.to | 139, 147, 161 |
| abstract_inverted_index.we | 205 |
| abstract_inverted_index.16% | 241 |
| abstract_inverted_index.28, | 59 |
| abstract_inverted_index.CI, | 137, 145, 159 |
| abstract_inverted_index.GC. | 54 |
| abstract_inverted_index.IHC | 238 |
| abstract_inverted_index.III | 44, 73 |
| abstract_inverted_index.TC, | 233 |
| abstract_inverted_index.TC. | 251 |
| abstract_inverted_index.and | 18, 89, 104, 118, 128, 141, 178, 195, 259, 263 |
| abstract_inverted_index.any | 99, 126, 151 |
| abstract_inverted_index.for | 40, 70, 82 |
| abstract_inverted_index.had | 90, 244 |
| abstract_inverted_index.not | 172 |
| abstract_inverted_index.one | 220 |
| abstract_inverted_index.the | 37, 71, 201, 207, 268 |
| abstract_inverted_index.was | 95, 114, 133, 171, 254 |
| abstract_inverted_index.(TC) | 103 |
| abstract_inverted_index.(any | 231 |
| abstract_inverted_index.36.2 | 138 |
| abstract_inverted_index.40.3 | 160 |
| abstract_inverted_index.IIIb | 7 |
| abstract_inverted_index.June | 58 |
| abstract_inverted_index.[95% | 136, 144, 158 |
| abstract_inverted_index.both | 98 |
| abstract_inverted_index.data | 202 |
| abstract_inverted_index.from | 64, 67 |
| abstract_inverted_index.more | 218 |
| abstract_inverted_index.part | 35 |
| abstract_inverted_index.sex, | 183 |
| abstract_inverted_index.than | 219 |
| abstract_inverted_index.were | 79, 163 |
| abstract_inverted_index.with | 48, 217, 225 |
| abstract_inverted_index.(GC). | 22 |
| abstract_inverted_index.(IHC) | 88 |
| abstract_inverted_index.(age, | 182 |
| abstract_inverted_index.16.2% | 142 |
| abstract_inverted_index.2+/3+ | 130, 153, 166 |
| abstract_inverted_index.2024, | 60 |
| abstract_inverted_index.3,782 | 61 |
| abstract_inverted_index.3,800 | 31 |
| abstract_inverted_index.37.8% | 134 |
| abstract_inverted_index.42.9% | 156 |
| abstract_inverted_index.cells | 102 |
| abstract_inverted_index.date, | 204 |
| abstract_inverted_index.level | 269 |
| abstract_inverted_index.newly | 49 |
| abstract_inverted_index.phase | 43, 72 |
| abstract_inverted_index.site, | 190 |
| abstract_inverted_index.study | 45 |
| abstract_inverted_index.third | 221 |
| abstract_inverted_index.trial | 75 |
| abstract_inverted_index.tumor | 32, 62, 101 |
| abstract_inverted_index.2+/3+) | 234 |
| abstract_inverted_index.39.3]) | 140 |
| abstract_inverted_index.45.4]) | 162 |
| abstract_inverted_index.FGFR2b | 25, 83, 93, 111, 122, 164, 169, 212, 228, 245, 252 |
| abstract_inverted_index.across | 116, 256 |
| abstract_inverted_index.assay. | 239 |
| abstract_inverted_index.cancer | 17, 21 |
| abstract_inverted_index.cutoff | 203 |
| abstract_inverted_index.factor | 3 |
| abstract_inverted_index.global | 42 |
| abstract_inverted_index.growth | 2 |
| abstract_inverted_index.method | 185 |
| abstract_inverted_index.nearly | 30 |
| abstract_inverted_index.report | 206 |
| abstract_inverted_index.sample | 119, 179, 264 |
| abstract_inverted_index.tested | 81 |
| abstract_inverted_index.tumor, | 194 |
| abstract_inverted_index.within | 175, 260 |
| abstract_inverted_index.≥10% | 105, 249 |
| abstract_inverted_index.(2+/3+) | 109 |
| abstract_inverted_index.(37.8%) | 222 |
| abstract_inverted_index.17.4]), | 148 |
| abstract_inverted_index.METHODS | 55 |
| abstract_inverted_index.PURPOSE | 0 |
| abstract_inverted_index.RESULTS | 121 |
| abstract_inverted_index.[biopsy | 186 |
| abstract_inverted_index.defined | 96, 261 |
| abstract_inverted_index.gastric | 16 |
| abstract_inverted_index.isoform | 6 |
| abstract_inverted_index.largest | 208 |
| abstract_inverted_index.notably | 173 |
| abstract_inverted_index.patient | 117, 177, 262 |
| abstract_inverted_index.primary | 193 |
| abstract_inverted_index.process | 39 |
| abstract_inverted_index.protein | 9, 26, 84, 123, 213, 229, 246 |
| abstract_inverted_index.regions | 258 |
| abstract_inverted_index.samples | 33, 63 |
| abstract_inverted_index.similar | 255 |
| abstract_inverted_index.tumors, | 155 |
| abstract_inverted_index.≥10%, | 129, 165 |
| abstract_inverted_index.(FGFR2b) | 8 |
| abstract_inverted_index.advanced | 51 |
| abstract_inverted_index.analyzed | 115 |
| abstract_inverted_index.assessed | 24 |
| abstract_inverted_index.emerging | 13 |
| abstract_inverted_index.examined | 181 |
| abstract_inverted_index.junction | 20 |
| abstract_inverted_index.location | 191 |
| abstract_inverted_index.multiple | 176 |
| abstract_inverted_index.patients | 47, 66, 224, 243 |
| abstract_inverted_index.receptor | 4 |
| abstract_inverted_index.region). | 197 |
| abstract_inverted_index.results. | 92 |
| abstract_inverted_index.biomarker | 14 |
| abstract_inverted_index.centrally | 80 |
| abstract_inverted_index.countries | 69 |
| abstract_inverted_index.diagnosed | 50 |
| abstract_inverted_index.different | 174 |
| abstract_inverted_index.evaluable | 91 |
| abstract_inverted_index.positive. | 168 |
| abstract_inverted_index.staining. | 112 |
| abstract_inverted_index.validated | 237 |
| abstract_inverted_index.variables | 265 |
| abstract_inverted_index.(612/1,428 | 157 |
| abstract_inverted_index.(612/3,782 | 143 |
| abstract_inverted_index.CONCLUSION | 198 |
| abstract_inverted_index.Fibroblast | 1 |
| abstract_inverted_index.Prevalence | 113 |
| abstract_inverted_index.assessment | 210 |
| abstract_inverted_index.collection | 184, 189 |
| abstract_inverted_index.exhibiting | 107, 227 |
| abstract_inverted_index.geographic | 196, 257 |
| abstract_inverted_index.membranous | 110 |
| abstract_inverted_index.metastatic | 53 |
| abstract_inverted_index.positivity | 94, 132 |
| abstract_inverted_index.prevalence | 28, 170, 209, 253 |
| abstract_inverted_index.regardless | 266 |
| abstract_inverted_index.expression. | 271 |
| abstract_inverted_index.identifier: | 77 |
| abstract_inverted_index.prescreened | 65 |
| abstract_inverted_index.resection], | 188 |
| abstract_inverted_index.(1,428/3,782 | 135 |
| abstract_inverted_index.NCT05052801) | 78 |
| abstract_inverted_index.prescreening | 38 |
| abstract_inverted_index.Approximately | 240 |
| abstract_inverted_index.FORTITUDE-101 | 74 |
| abstract_inverted_index.TC–positive | 154 |
| abstract_inverted_index.respectively. | 149 |
| abstract_inverted_index.overexpression | 10, 27, 85, 124, 214, 230, 247 |
| abstract_inverted_index.characteristics | 180 |
| abstract_inverted_index.characteristics. | 120 |
| abstract_inverted_index.gastroesophageal | 19 |
| abstract_inverted_index.moderate-to-strong | 108 |
| abstract_inverted_index.(ClinicalTrials.gov | 76 |
| abstract_inverted_index.immunohistochemistry | 87 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| countries_distinct_count | 13 |
| institutions_distinct_count | 18 |
| citation_normalized_percentile.value | 0.99430174 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |